South Korea's Samsung Biologics rallies after avoiding delisting

South Korea's Samsung Biologics rallies after avoiding delisting

Samsung BioLogics Co. signage is seen behind medicine bottles on display at the company's headquarters and production facilities in Songdo district in Incheon, South Korea, on Wednesday, April 19, 2017. Photographer: SeongJoon Cho/Bloomberg

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter